Larson Jeffrey Leroy
SEC insider (Form 3/4/5 filer). CIK 0002064985. SVP, Research & Development at Tvardi Therapeutics, Inc. (TVRD). 3 reported Form 4/5 transactions since Sep 2024; latest on Apr 17, 2025. Located in SUGAR LAND, TX.
Companies Larson Jeffrey Leroy has filed insider reports for
- Tvardi Therapeutics, Inc. (TVRD): Officer, SVP, Research & Development
Larson Jeffrey Leroy
CIK: 0002064985
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tvardi Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Apr 17, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
10.8K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
16.8K shares- - Apr 15, 2025TVRD
Tvardi Therapeutics, Inc.
AwardDirectEmployee Stock Option (right to buy)
5.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 17, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 10,820 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 16,764 | - | - | Direct |
| Apr 15, 2025 | TVRD Tvardi Therapeutics, Inc. | Award Employee Stock Option (right to buy) | 5,364 | - | - | Direct |
1-3 of 3 transactions